High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis
- 1 January 1998
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 111 (1), 64-69
- https://doi.org/10.1046/j.1365-2249.1998.00468.x
Abstract
Some patients develop post-kala-azar dermal leishmaniasis (PKDL) after they have been treated for the systemic infection kala-azar (visceral leishmaniasis). It has been an enigma why the parasites cause skin symptoms after the patients have been successfully treated for the systemic disease. We report here that PKDL development can be predicted before treatment of visceral leishmaniasis, and that IL-10 is involved in the pathogenesis. Before treatment of visceral leishmaniasis, Leishmania parasites were present in skin which appeared normal on all patients. However, IL-10 was detected in the keratinocytes and/or sweat glands of all patients who later developed PKDL (group 1) and not in any of the patients who did not develop PKDL (group 2). Furthermore, the levels of IL-10 in plasma as well as in peripheral blood mononuclear cell culture supernatants were higher in group 1 than in group 2.Keywords
This publication has 20 references indexed in Scilit:
- Successful Chemotherapy in Experimental Leishmaniasis Is Influenced by the Polarity of the T Cell Response Before TreatmentThe Journal of Infectious Diseases, 1996
- The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an exampleImmunology Today, 1996
- Interleukin‐10 inhibits IgE‐mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytesEuropean Journal of Immunology, 1995
- Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.The Journal of Experimental Medicine, 1995
- Potential role for interleukin-10 in the immunosuppression associated with kala azar.Journal of Clinical Investigation, 1993
- Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivoEuropean Journal of Immunology, 1993
- Interleukin 10 production correlates with pathology in human Leishmania donovani infections.Journal of Clinical Investigation, 1993
- In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.Journal of Clinical Investigation, 1993
- The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patientsClinical and Experimental Immunology, 1992
- Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatmentTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992